Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product & Service(Reagents, Kits, And Consumables, Instruments), By Type of Testing(Laboratory Testing, POC Testing), By Sample Type(Blood, Serum, and Plasma, Urine), By Disease Type(Hepatitis (Hepatitis B, Hepatitis C, Other Hepatitis Diseases), HIV), By Technology(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology), By End User(Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users), By Region - Industry Forecast 2024-2031

North America region in the infectious disease diagnostics market accounted for 38.49% of the global market in 2023. The industry is expected to keep expanding at lucrative growth during the forecast period with favorable & flexible regulatory framework. Presence of major manufacturers offering new IVD products, more testing and focus on disease management are the major factors driving the North America region. For example, in August 2023, the FDA provided a BD Vaginal Panel in the BD COR program to identify infectious agents that cause vaginal infections. The market for infectious diseases in the United States is expected to grow during the forecast period. The outbreak of COVID-19 dramatically changed the market landscape of diagnostics as companies engaged in test development with faster and more efficient turnaround times.  

Asia Pacific is anticipated to witness significant growth in the market due to the high prevalence of infectious diseases, and the increasing demand for healthcare in emerging economies such as India and China are fueling the growth of the sector. The growing elderly population in countries such as Japan is also acting as a catalyst for the adoption of IVD screening. Rapid economic growth in the region and emerging market players are expected to drive the adoption of new diagnostic tests for infectious diseases in the community. The infectious diseases infectious disease diagnostics market in China is expected to grow during the forecast period. Increased need for early diagnosis, increased focus on new technology devices, and increasing levels of collaboration between leading partners & individual laboratories.